B3461077 amsdenmb Thu, 05/21/2026 - 14:31 Vyndamax Tafamidis PHASE IV Thu, 07/22/2021 - 12:00 Mon, 10/16/2023 - 12:00 NCT04814186 B3461077 Public Disclosure Synopsis _0.pdf (106.49 KB) N https://clinicaltrials.gov/study/NCT04814186?term=NCT04814186&viewType=Card&rank=1 B3461077
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules